Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence
Annals of Pediatric Cardiology · 2019 · 12 (1) · 18
DOI: 10.4103/apc.apc_47_18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pediatric Cardiology, 2019. Verfasst von Fátima Derlene da Rocha Araújo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Cardiology, Hospital das Clínicas, Federal University of Minas Gerais, Belo Horizonte, Brazil. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Cardiology, Hospital das Clínicas, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Internal Medicine, Division of Cardiology, Hospital das Clínicas, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Zitieren
APA
Araújo, F. D. D. R., Silva, R. M. F. D. L., Oliveira, C. A. L., & Meira, Z. M. A. (2019). Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence. Annals of Pediatric Cardiology, 12(1), 18. https://doi.org/10.4103/apc.apc_47_18
Vancouver
Araújo FDDR, Silva RMFDL, Oliveira CAL, Meira ZMA. Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence. Annals of Pediatric Cardiology. 2019;12(1):18. doi:10.4103/apc.apc_47_18
BibTeX
@article{Arajo2019,
author = {Araújo, Fátima Derlene da Rocha and Silva, Rose Mary Ferreira da Lisboa and Oliveira, Camilla Andrade Lima and Meira, Zilda Maria Alves},
title = {Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence},
journal = {Annals of Pediatric Cardiology},
year = {2019},
volume = {12},
number = {1},
pages = {18},
doi = {10.4103/apc.apc_47_18}
}
EUVIMED